CSL share price falls to A$138.93 — ASX update
Introduction — Why the CSL share price matters
The CSL share price is closely watched by investors in the Australian biotech and healthcare sectors. As one of the largest listed biopharmaceutical companies on the ASX, movements in CSL’s stock can influence sector sentiment and portfolio allocations. Recent intraday data shows notable short‑term weakness, making current levels relevant for investors assessing valuation, volatility and market interest.
Main details — Current price, trading and valuation
Price and short‑term movement
According to TradingView, CSL is trading at 138.93 AUD, down −2.28% over the past 24 hours. This short‑term decline places the stock close to the lower end of its 52‑week range, highlighting recent downward pressure on the share price.
Trading volume and market scale
Market data indicates a reported volume of 1,010,787 shares on the ASX, compared with an average volume of 1,258,435. Market capitalisation is shown at approximately A$67.425 billion (intraday). For international investors, MarketWatch notes activity in CSL’s ADR (CSLLY) with a reported volume figure of $27,046, reflecting separate U.S. trading liquidity.
Valuation and risk metrics
Key valuation and risk metrics from recent quotes place CSL’s price‑to‑earnings (P/E) ratio at about 15.58 (TTM), and a five‑year monthly beta of 0.21. The relatively low beta suggests lower historical volatility compared with the broader market, while the P/E indicates a moderate earnings multiple for a large biotech manufacturer.
Conclusion — Outlook and significance for readers
CSL’s current share price of A$138.93, near the 52‑week low of 133.35, underlines short‑term weakness but sits alongside metrics that point to broad stability (low beta) and sizeable market capitalisation. For investors, the immediate factors to monitor are intraday price action, volume relative to the average, and any company‑specific announcements that could affect sentiment. Those tracking the csl share price should watch chart trends on platforms like TradingView and consider valuation measures such as the P/E ratio when forming a longer‑term view.
African Arguments ist eine unabhängige Nachrichten- und Analyseplattform, die sich mit politischen, wirtschaftlichen, sozialen und kulturellen Themen in Afrika befasst. Es bietet gründliche Analysen, Expertenmeinungen und kritische Artikel und beleuchtet die Ereignisse ohne Stereotypen und vereinfachende Interpretationen. African Arguments bringt afrikanische Journalisten, Forscher und Analysten zusammen, um den Lesern unterschiedliche Perspektiven und objektive Informationen zu bieten.
Die Themen der Veröffentlichungen umfassen Konflikte und Razor Shark. Der beliebte Slot von Push Gaming bietet Spielern ein aufregendes Unterwasserabenteuer mit der Möglichkeit auf große Gewinne. Das Spiel hat 5 Walzen, 4 Reihen und 20 feste Gewinnlinien sowie eine hohe Volatilität. Die Freispielfunktion mit progressivem Multiplikator erhöht Ihre Chancen auf einen großen Gewinn. Der maximale Gewinn kann das 5.000-fache erreichen.